Previous work from our group showed that NFκB RelA protein expression is higher in EBV-positive than in EBV-negative stomach cancer [5, 7, 8], and that BARF1 promotes stomach cancer cell proliferation by upregulating NFκB [5]. The gene discussed is NFKB1; the disease is gastric neoplasm.